QRVO
29
-18
EIX
56
3
COST
66
5
FIS
43
5
ZTS
65
27
MCO
73
2
SYF
95
3
HES
74
2
GE
70
3
ADP
57
-7
JNPR
43
-3
CFG
44
18
DD
56
-12
TMO
60
-3
PLD
51
13
UNP
50
4
KLAC
63
5
CTAS
55
3
BRK.B
49
2
AAPL
65
4
QRVO
29
-18
EIX
56
3
COST
66
5
FIS
43
5
ZTS
65
27
MCO
73
2
SYF
95
3
HES
74
2
GE
70
3
ADP
57
-7
JNPR
43
-3
CFG
44
18
DD
56
-12
TMO
60
-3
PLD
51
13
UNP
50
4
KLAC
63
5
CTAS
55
3
BRK.B
49
2
AAPL
65
4
Financhill
Back

Genetic Technologies 10K Form

Sell
36

GENE
Genetic Technologies

Last Price:
2.29
Seasonality Move:
1.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GENE News And Ratings

See the #1 stock for the next 7 days that we like better than GENE

GENE Financial Statistics

Sales & Book Value

Annual Sales: $5.84M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.71
Price / Book: 0

Profitability

EPS (TTM): -0.60400
Net Income (TTM): $-4.08M
Gross Margin: $2.93M
Return on Equity: 0%
Return on Assets: 0%

Genetic Technologies Earnings Forecast

Key Genetic Technologies Financial Ratios

  • The Gross Profit Margin over the past 20 years for GENE is 50.09%.
  • The Selling, General & Administrative Expenses for GENE have been equal to 134.98% of Gross Profit Margin.
  • The Research & Development expenses have been 14.75% of Revenue.
  • The Interest Expense is -0.25% of Operating Income.
  • The Net Earning history of GENE is -135.28% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 15 years.

Genetic Technologies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: GENE
CUSIP: 37185R
Website: gtglabs.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GENE Technical Analysis vs Fundamental Analysis

Sell
36
Genetic Technologies (GENE) is a Sell

Is Genetic Technologies a Buy or a Sell?